Menu
Peptide Database
Results
No peptides found
Featured

Use search to browse all 100+ peptides

LL-37

Cathelicidin, hCAP-18, FALL-39, CAP-18

Quick Stats
Studies 2230
Trials 95
Score 2
2009 pubmed

Primate cathelicidin orthologues display different structures and membrane interactions.

Morgera. Francesca F; Vaccari. Lisa L; Antcheva. Nikolinka N; Scaini. Denis D; Pacor. Sabrina S; Tossi. Alessandro A

Key Findings

  • Monkey (RL‑37) is monomeric and inserts deeper into membranes, showing stronger direct antibacterial action
  • Human LL‑37 tends to aggregate, leading to a carpet‑like membrane disruption and more host‑cell modulation
  • Structural balance of charged residues determines peptide aggregation and functional trade‑offs

Practical Outcomes

  • If you’re looking for a peptide that mainly kills microbes, a monomeric, non‑aggregating form like RL‑37 may be more effective. Human LL‑37’s tendency to aggregate suggests it could be better for modulating immune responses rather than pure antimicrobial use. Designing or selecting LL‑37 analogs with reduced aggregation could boost antibacterial potency.

Summary

Different versions of the LL‑37 peptide in primates have distinct shapes and how they stick together, which changes how they interact with cell membranes. The monkey version stays as single pieces and can slip deeper into membranes, acting more like a straight‑up antimicrobial. The human version tends to clump together, which reduces its direct killing power but may help it influence host cells.

Abstract

The human cathelicidin LL-37 displays both direct antibacterial activities and the capacity to modulate host-cell activities. These depend on structural characteristics that are subject to positive selection for variation, as observed in a previous analysis of the CAMP gene (encoding LL-37) in primates. The altered balance between cationic and anionic residues in different primate orthologues affects intramolecular salt-bridging and influences the stability of the helical conformation and tendency to aggregate in solution of the peptide. In the present study, we have analysed the effects of these structural variations on membrane interactions for human LL-37, rhesus RL-37 and orang-utan LL-37, using several complementary biophysical and biochemical methods. CD and ATR (attenuated total reflection)-FTIR (Fourier-transform IR) spectroscopy on model membranes indicate that RL-37, which is monomeric and unstructured in bulk solution [F-form (free form)], and human LL-37, which is partly structured and probably aggregated [A-form (aggregated form)], bind biological membranes in different manners. RL-37 may insert more deeply into the lipid bilayer than LL-37, which remains aggregated. AFM (atomic force microscopy) performed on the same supported bilayer as used for ATR-FTIR measurements suggests a carpet-like mode of permeabilization for RL37 and formation of more defined worm-holes for LL-37. Comparison of data from the biological activity on bacterial cells with permeabilization of model membranes indicates that the structure/aggregation state also affects the trajectory of the peptides from bulk solution through the outer cell-wall layers to the membrane. The results of the present study suggest that F-form cathelicidin orthologues may have evolved to have primarily a direct antimicrobial defensive capacity, whereas the A-forms have somewhat sacrificed this to gain host-cell modulating functions.

Study Information

Provider

pubmed

Year

2009

Date

2009-02-01T00:00:00.000Z

DOI

10.1042/bj20081726